These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 7609554)
21. Impact of pulmonary vascular resistances in heart transplantation for congenital heart disease. Gazit AZ; Canter CE Curr Cardiol Rev; 2011 May; 7(2):59-66. PubMed ID: 22548028 [TBL] [Abstract][Full Text] [Related]
22. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease. Limsuwan A; Khosithseth A; Wanichkul S; Khowsathit P Catheter Cardiovasc Interv; 2009 Jan; 73(1):98-104. PubMed ID: 19089967 [TBL] [Abstract][Full Text] [Related]
23. Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome. Cacoub P; Dorent R; Maistre G; Nataf P; Carayon A; Piette C; Godeau P; Cabrol C; Gandjbakhch I Am J Cardiol; 1993 Feb; 71(5):448-50. PubMed ID: 8430638 [No Abstract] [Full Text] [Related]
24. [Stages of heart defects as a reflection of the compensation--para-compensation development]. Meshalkin EN; Litasova EE; Vlasov IuA; Okuneva GN; Chasovskikh GG Vestn Akad Med Nauk SSSR; 1991; (7):50-4. PubMed ID: 1838225 [No Abstract] [Full Text] [Related]
25. Can "inoperable" congenital heart defects become operable in patients with pulmonary arterial hypertension? Dream or reality? Beghetti M; Galiè N; Bonnet D Congenit Heart Dis; 2012; 7(1):3-11. PubMed ID: 22233186 [TBL] [Abstract][Full Text] [Related]
26. Regulation of the pulmonary circulation. Linde LM; Simmons DH UCLA Forum Med Sci; 1970; 10():321-9. PubMed ID: 5521145 [No Abstract] [Full Text] [Related]
27. [Assessment of pulmonary hypertension in congenital heart defects in childhood]. Beuren AJ Klin Padiatr; 1972 Jan; 184(1):1-3. PubMed ID: 5063475 [No Abstract] [Full Text] [Related]
28. Plasma endothelin 1 concentrations in children with congenital heart defects. Jia B; Zhang S; Chen Z; Li Z; Li X; Hui W; Ye M Minerva Pediatr; 1998 Apr; 50(4):99-103. PubMed ID: 9808961 [TBL] [Abstract][Full Text] [Related]
29. Decreased levels of serum Angiotensin-(1-7) in patients with pulmonary arterial hypertension due to congenital heart disease. Dai H; Gong Y; Xiao Z; Guang X; Yin X Int J Cardiol; 2014 Oct; 176(3):1399-401. PubMed ID: 25150487 [No Abstract] [Full Text] [Related]
30. Assessment of operability of congenital cardiac shunts with increased pulmonary vascular resistance. Viswanathan S; Kumar RK Catheter Cardiovasc Interv; 2008 Apr; 71(5):665-70. PubMed ID: 18360864 [TBL] [Abstract][Full Text] [Related]
31. [The changes of plasma endothelin concentration and its clinical significance in pulmonary hypertension associated with congenital heart defects]. Zhang S; Qi S; Shen X; Zhou S; Jin S Hunan Yi Ke Da Xue Xue Bao; 1997; 22(5):425-7. PubMed ID: 10073026 [TBL] [Abstract][Full Text] [Related]
36. Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy. Dimopoulos K; Peset A; Gatzoulis MA Int J Cardiol; 2008 Sep; 129(2):163-71. PubMed ID: 18367267 [TBL] [Abstract][Full Text] [Related]